Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis [5]

Lancet

Volumn 349, Issue 9069, 1996, Pages 1886-1887

  Stahel, Philip F ^b   Nadal, David ^b   Pfister, Hans Walter ^b   Paradisis, P Maria ^b   Barnum, Scott R ^a  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BACTERIAL ANTIGEN; COMPLEMENT COMPONENT C3;

ADOLESCENT; ADULT; AGED; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; LETTER; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030604552     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63877-9     Document Type: Article

References (3)

1. 1 Lindquist L, Linné T, Hansson L-O, Kalin M, Axelsson G. Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis 1988; 7: 374-80.
2. 2 Rodewald LE, Woodin KA, Szilagyi PG, Arvan DA, Raubertas RF, Powell KR. Relevance of common tests of cerebrospinal fluid in screening for bacterial meningitis. J Pediatr 1991; 119: 363-69.
3. 3 Stahel PF, Barnum SR. Bacterial meningitis: complement gene expression in the central nervous system. Immunopharmacology. (In press)